PCSA insider buying
2 cluster buysProcessa Pharmaceuticals, Inc. · Healthcare
When two or more insiders at Processa Pharmaceuticals, Inc. buy PCSA on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in PCSA plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.
Detected clusters
- Mar 31 – Mar 31, 2026Detected Mar 31, 2026High conviction8 insidersTotal bought$41.0KMarket cap$5.8M
- Jan 27 – Jan 27, 2025Detected Jan 27, 2025High conviction4 insidersTotal bought$214.1KMarket cap$5.8M
All notable open-market buys in PCSA
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Mar 31, 2026 | SKIBSTED RUSSELLcluster Chief Financial Officer | 2,324 | $2.54 | $5.9K | SEC ↗ |
| Mar 31, 2026 | Baluch Khosocluster Director | 2,269 | $2.54 | $5.8K | SEC ↗ |
| Mar 31, 2026 | Ng George Kcluster Director, Chief Executive Officer | 2,136 | $2.54 | $5.4K | SEC ↗ |
| Mar 31, 2026 | Bigora Siancluster Chief Development Officer | 2,107 | $2.54 | $5.3K | SEC ↗ |
| Mar 31, 2026 | Pannu Geraldinecluster Director | 2,072 | $2.54 | $5.3K | SEC ↗ |
| Mar 31, 2026 | Guy Wendycluster Chief Administrative Officer | 1,854 | $2.54 | $4.7K | SEC ↗ |
| Mar 31, 2026 | Young Davidcluster Director, Pres. Research & Development | 1,810 | $2.54 | $4.6K | SEC ↗ |
| Mar 31, 2026 | Lin Patrickcluster Chief Business - Strategy Off | 1,603 | $2.54 | $4.1K | SEC ↗ |
| Jan 27, 2025 | Young Davidcluster Director, Pres. Research & Development | 124,500 | $0.80 | $99.6K | SEC ↗ |
| Jan 27, 2025 | Ng George Kcluster Director, Chief Executive Officer | 87,200 | $0.80 | $69.8K | SEC ↗ |
| Jan 27, 2025 | Lin Patrickcluster Chief Business - Strategy Off | 43,500 | $0.80 | $34.8K | SEC ↗ |
| Jan 27, 2025 | Yorke Justin Wcluster Director | 12,400 | $0.80 | $9.9K | SEC ↗ |
More Healthcare stocks with insider cluster buys
PCSA insider buying — FAQ
- Are insiders buying PCSA stock?
- Yes — 9 distinct insiders have bought PCSA (Processa Pharmaceuticals, Inc.) on the open market, including 2 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Apr 1, 2026.
- How much PCSA stock have insiders bought?
- Insiders have bought a combined $255.1K of PCSA across 12 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in PCSA?
- A cluster buy is two or more distinct Processa Pharmaceuticals, Inc. insiders — officers, directors, or 10% owners — each buying PCSA on the open market within a rolling window. PCSA has 2 detected cluster buys to date.
- Where does this PCSA insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in PCSA
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy PCSA within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding PCSA.